Johnson Investment Counsel Inc. Buys 898 Shares of Intuitive Surgical, Inc. $ISRG

Johnson Investment Counsel Inc. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 29,042 shares of the medical equipment provider’s stock after acquiring an additional 898 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in Intuitive Surgical were worth $15,782,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Chilton Capital Management LLC increased its position in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. bought a new position in shares of Intuitive Surgical in the first quarter valued at $26,000. LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical in the first quarter valued at $30,000. TD Capital Management LLC boosted its holdings in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical during the first quarter worth about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $429.59 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm’s fifty day moving average is $458.68 and its 200 day moving average is $497.91. The firm has a market cap of $154.00 billion, a P/E ratio of 59.91, a P/E/G ratio of 4.51 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the firm earned $1.78 EPS. The firm’s quarterly revenue was up 21.4% compared to the same quarter last year. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

Several analysts have commented on the stock. The Goldman Sachs Group lowered their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research report on Wednesday, October 1st. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Wednesday. BTIG Research reissued a “buy” rating and issued a $571.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 1st. Finally, Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $589.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.